Free Trial

MEDIROM Healthcare Technologies (MRM) Competitors

→ Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad)
Free MRM Stock Alerts
$5.95
-0.02 (-0.34%)
(As of 05:27 PM ET)
Compare
Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media

MRM vs. FEMY, EVGN, OMIC, SPRB, PRE, LEXX, VIRX, NMTC, PLUR, and CASI

Should you be buying MEDIROM Healthcare Technologies stock or one of its competitors? The main competitors of MEDIROM Healthcare Technologies include Femasys (FEMY), Evogene (EVGN), Singular Genomics Systems (OMIC), Spruce Biosciences (SPRB), Prenetics Global (PRE), Lexaria Bioscience (LEXX), Viracta Therapeutics (VIRX), NeuroOne Medical Technologies (NMTC), Pluri (PLUR), and CASI Pharmaceuticals (CASI). These companies are all part of the "medical" sector.

MEDIROM Healthcare Technologies vs.

MEDIROM Healthcare Technologies (NYSE:MRM) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

MEDIROM Healthcare Technologies has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500. Comparatively, Femasys has a beta of -3, indicating that its share price is 400% less volatile than the S&P 500.

65.3% of Femasys shares are owned by institutional investors. 40.2% of MEDIROM Healthcare Technologies shares are owned by company insiders. Comparatively, 16.4% of Femasys shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, MEDIROM Healthcare Technologies had 1 more articles in the media than Femasys. MarketBeat recorded 2 mentions for MEDIROM Healthcare Technologies and 1 mentions for Femasys. Femasys' average media sentiment score of 0.76 beat MEDIROM Healthcare Technologies' score of 0.00 indicating that Femasys is being referred to more favorably in the news media.

Company Overall Sentiment
MEDIROM Healthcare Technologies Neutral
Femasys Positive

Femasys has a consensus target price of $11.33, indicating a potential upside of 752.13%. Given Femasys' higher possible upside, analysts plainly believe Femasys is more favorable than MEDIROM Healthcare Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MEDIROM Healthcare Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Femasys
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

MEDIROM Healthcare Technologies has a net margin of 0.00% compared to Femasys' net margin of -1,329.10%. MEDIROM Healthcare Technologies' return on equity of 0.00% beat Femasys' return on equity.

Company Net Margins Return on Equity Return on Assets
MEDIROM Healthcare TechnologiesN/A N/A N/A
Femasys -1,329.10%-105.47%-80.50%

MEDIROM Healthcare Technologies has higher revenue and earnings than Femasys.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MEDIROM Healthcare Technologies$53.25M0.55$1.15MN/AN/A
Femasys$1.07M27.47-$14.25M-$0.92-1.45

Femasys received 21 more outperform votes than MEDIROM Healthcare Technologies when rated by MarketBeat users.

CompanyUnderperformOutperform
MEDIROM Healthcare TechnologiesN/AN/A
FemasysOutperform Votes
21
63.64%
Underperform Votes
12
36.36%

Summary

MEDIROM Healthcare Technologies beats Femasys on 8 of the 14 factors compared between the two stocks.

Get MEDIROM Healthcare Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MRM vs. The Competition

Export to Excel
MetricMEDIROM Healthcare TechnologiesPersonal services IndustryMedical SectorNYSE Exchange
Market Cap$29.15M$1.15B$4.86B$17.44B
Dividend YieldN/A2.21%2.97%3.53%
P/E RatioN/A218.80185.6821.98
Price / Sales0.5534.912,426.4110.32
Price / Cash11.4030.7146.7517.77
Price / Book-66.3317.774.584.86
Net Income$1.15M$45.86M$102.93M$964.96M
7 Day Performance-1.81%0.78%0.20%1.22%
1 Month Performance-3.71%-3.49%-6.66%-2.16%
1 Year Performance4.74%-16.91%9.27%103.12%

MEDIROM Healthcare Technologies Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FEMY
Femasys
2.9368 of 5 stars		$1.31
-2.2%		$11.33
+765.1%		+60.0%$28.95M$1.07M-1.4234Short Interest ↓
Positive News
EVGN
Evogene
2.7505 of 5 stars		$0.70
+1.4%		$3.62
+416.7%		+15.6%$28.85M$5.64M-1.32137Analyst Report
Short Interest ↓
Gap Down
OMIC
Singular Genomics Systems
2.8249 of 5 stars		$0.39
+2.6%		$0.68
+73.1%		-59.9%$28.83M$2.91M-0.30255Short Interest ↓
Gap Up
High Trading Volume
SPRB
Spruce Biosciences
3.8548 of 5 stars		$0.70
-1.4%		$5.67
+709.3%		-66.0%$28.81M$10.09M-0.5629Short Interest ↓
PRE
Prenetics Global
1.3316 of 5 stars		$3.21
-8.0%		$9.00
+180.4%		-59.5%$29.34M$21.74M-0.67400Short Interest ↑
News Coverage
Gap Down
LEXX
Lexaria Bioscience
1.6688 of 5 stars		$2.31
+16.1%		$12.00
+419.5%		-0.5%$29.78M$230,000.00-3.405Positive News
VIRX
Viracta Therapeutics
1.2683 of 5 stars		$0.71
-8.9%		$5.00
+599.5%		-35.8%$28.07MN/A-0.5440Gap Up
High Trading Volume
NMTC
NeuroOne Medical Technologies
2.0024 of 5 stars		$1.15
+2.7%		$2.20
+91.3%		-29.3%$29.82M$1.95M-1.6916Short Interest ↓
Gap Down
PLUR
Pluri
0 of 5 stars		$5.76
+1.6%		N/A-37.5%$29.84M$290,000.00-1.24123Short Interest ↑
Negative News
CASI
CASI Pharmaceuticals
4.2954 of 5 stars		$2.25
-10.0%		$12.00
+433.3%		-22.6%$30.15M$33.88M-1.11176Short Interest ↓
Gap Up

Related Companies and Tools

Related Companies:
Top 10 Stock Comparisons
This page (NYSE:MRM) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
He Is Giving Away Bitcoin
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Man Who Predicted 2008: “This Will be Worse.”
Altimetry
Fed launches fourth dollar overhaul
Stansberry Research
Biden out June 13; Kamala won’t replace him?
Paradigm Press